BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:China Standard Time BEGIN:STANDARD DTSTART:16010101T000000 TZOFFSETFROM:+0800 TZOFFSETTO:+0800 END:STANDARD END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20221013T090129Z DESCRIPTION:Join the live conference \n \n** Please note live str eaming won’t be accessible until Tuesday. November 1\, 2022.\n \nOrigina l language: Chinese\n \nChina’s National Healthcare Security Administrat ion (NHSA) has conducted a number of reforms since 2018\, lowering key med ication price with a market economy mechanism\, while earlier the National Medical Products Administration (NMPA) accelerated the approvals process for new drugs. These policies have been widely praised by consumers and ha ve important read-through to manufacturers\, but many challenges remain: s uch as geographically unevenly distributed healthcare and the conflict bet ween ever growing healthcare demand and preventing healthcare expenditure to balloon.\n \nHear from a leading academic on how China is balancing its goal of universal access to healthcare with the benefits of an efficient\ , free market for innovative healthcare product manufacturing and developm ent. Faced with momentous decisions\, how will policymakers decide their priorities in future healthcare reform? And what levels of expenditure can healthcare providers\, insurers\, suppliers and patients expect?\n \nSpea ker(s):\n* Bin Jiang\, Associate Professor\, Department of Pharmacy Admini stration and Clinical Pharmacy\, Peking University\n* Host: Yang Huang\, H ead of China Healthcare Securities Research\, Credit Suisse\n \n \n DTEND;TZID="China Standard Time":20221102T120000 DTSTAMP:20221003T071824Z DTSTART;TZID="China Standard Time":20221102T110000 LAST-MODIFIED:20221013T090129Z LOCATION:Virtual Conference PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=en-us:Credit Suisse China Investment Conference 2022 | Con versation: What's next in China's long-running healthcare reforms? TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000F0D41F2E3BD7D801000000000000000 010000000B97BF43478784C46AAF1C9A4CAA39BDA X-ALT-DESC;FMTTYPE=text/html:

Join the live conference

 \;

** Please no te live streaming won’t be accessible until Tuesday. November 1\, 2022.< o:p>

 \;

Origin al language: Chinese

 \;

China’s National Healthcare Security Administration (NHSA ) has conducted a number of reforms since 2018\, lowering key medication p rice with a market economy mechanism\, while earlier the National Medical Products Administration (NMPA) accelerated the approvals process for new d rugs. These policies have been widely praised by consumers and have import ant read-through to manufacturers\, but many challenges remain: such as ge ographically unevenly distributed healthcare and the conflict between ever growing healthcare demand and preventing healthcare expenditure to balloo n.

 \;

Hea r from a leading academic on how China is balancing its goal of universal access to healthcare with the benefits of an efficient\, free market for i nnovative healthcare product manufacturing and development. \; \;F aced with momentous decisions\, how will policymakers decide their priorit ies in future healthcare reform? And what levels of expenditure can health care providers\, insurers\, suppliers and patients expect?

 \;

Speaker(s):

  • Bin Jiang\, Associate Professo r\, Department of Pharmacy Administration and Clinical Pharmacy\, Peking U niversity
  • Host: \;Yang Huang\, Head of China Healthc are Securities Research\, Credit Suisse

 \;

 \;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR